Correlation Between Centessa Pharmaceuticals and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Inhibrx, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Inhibrx.
Diversification Opportunities for Centessa Pharmaceuticals and Inhibrx
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Centessa and Inhibrx is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Inhibrx go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and Inhibrx
Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 1.14 times more return on investment than Inhibrx. However, Centessa Pharmaceuticals is 1.14 times more volatile than Inhibrx. It trades about 0.26 of its potential returns per unit of risk. Inhibrx is currently generating about -0.16 per unit of risk. If you would invest 1,515 in Centessa Pharmaceuticals PLC on August 24, 2024 and sell it today you would earn a total of 304.00 from holding Centessa Pharmaceuticals PLC or generate 20.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. Inhibrx
Performance |
| Timeline |
| Centessa Pharmaceuticals |
| Inhibrx |
Centessa Pharmaceuticals and Inhibrx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Centessa Pharmaceuticals and Inhibrx
The main advantage of trading using opposite Centessa Pharmaceuticals and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.The idea behind Centessa Pharmaceuticals PLC and Inhibrx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |